PF-Atlas › Clinical Trials › NCT02550873

A Trial to Evaluate the Efficacy of PRM-151 in Subjects With Idiopathic Pulmonary Fibrosis

PRM-151 · Phase 2

Registry ID

NCT02550873

Phase

Phase 2

Status

Completed

Drug / intervention

PRM-151

Sponsor

Hoffmann-La Roche

Start

2015-09-01

Enrollment

117

Locations

About this trial

This study is a Phase 2, randomized, double-blind, placebo controlled, pilot study designed to evaluate the efficacy and safety of PRM-151 administered through Week 24 to subjects with IPF.

View NCT02550873 on ClinicalTrials.gov →

Explore related

All PRM-151 trials All IPF trials

Related trials

PRM-151 — NCT04594707

Medical disclaimer. This page summarizes public trial data for NCT02550873 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.